Hospital Medicine Alert
RSSArticles
-
To Cut Or Not To Cut
ABSTRACT & COMMENTARY: Here are the benefits and the downsides of doing an early cholecystectomy.
-
Valve Disease and Thromboembolic Risk
The CHA2DS2-VASc score for the prediction of stroke and other thromboembolism risk in patients with atrial fibrillation has been validated in patients with non-valvular atrial fibrillation.
-
Using Procalcitonin to Differentiate Bacterial from Viral Meningitis
SYNOPSIS: A meta-analysis based on nine studies found an elevated serum procalcitonin to be an accurate test for differentiating bacterial from viral meningitis in adults.
-
Could High-flow Oxygen Therapy Impact Acute Respiratory Failure Management?
SYNOPSIS: Managing acute hypoxemic respiratory failure with high-flow nasal cannula (HFNC) significantly reduced intubation rates compared to standard oxygen (O2) mask delivery and non-invasive ventilation among patients whose arterial O2 tension to inspired O2 fraction ratio (PaO2/FiO2) was < 200. Among all study patients, hospital mortality was lower in the HFNC group.
-
Role of Transthoracic Echo in Staph Bacteremia
In patients without community-acquired Staph bacteremia, a high-risk cardiac condition, or IV drug use, a negative transthoracic echo excluded infective endocarditis.
-
The Pros and Cons of Central Venous Catheterization Sites
ABSTRACT AND COMMENTARY: Improper placement can lead to a deep vein thrombosis or a blood stream infection. Here's guidance on doing it right.
-
Serum Chloride Level Predicts Mortality in Acute Heart Failure
The association between serum sodium level and outcomes in acute decompensated heart failure is well-established.
-
Community-acquired Pneumonia Requiring Hospitalization in Adults
An active population-based surveillance of community-acquired pneumonia requiring hospitalization in adults 18 years of age and older was conducted in five hospitals in Chicago and Nashville. -
Idarucizumab: A Promising New Drug that Reverses the Anticoagulant Effects of Dabigatran
Several new oral anticoagulants are changing the approach to anticoagulation for patients with nonvalvular atrial fibrillation and deep venous thrombosis/pulmonary emboli.
-
Optimal Duration of Anticoagulation for Unprovoked Pulmonary Embolism
The PADIS-PE study is a randomized, double-blind trial of adult patients with a first episode of unprovoked PE that seeks to better define the appropriate duration of therapy.